Yocca Frank

Chief Scientific Officer at BTAI

Sold, on record
$3.9M
Dollars the filings state
Form 4 sales
11
Latest May 20, 2026
Form 144 notices
5
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • BTAIBioXcel Therapeutics, Inc.Chief Scientific Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale BTAIRoutine
    Jun 17, 2024 2024

    Sold 372 shares at $1.28 ($476)

    Yocca Frank, Chief Scientific Officer

    10b5-1 planSold 2.7% of holdings ($18k position)13,474 shares left0.3x usual sizeFollows a Form 144Filing

  2. 2 Form 144 notice BTAINotice
    Sep 16, 2024 +91 days

    Filed to sell 355 shares ($245)

    Yocca Frank, Officer

    10b5-1 plan0.3x usual sizeFiling

  3. 3 Form 4 sale BTAIRoutine
    Sep 16, 2024 same day

    Sold 355 shares at $0.69 ($245)

    Yocca Frank, Chief Scientific Officer

    10b5-1 planSold 2.4% of holdings ($10k position)14,203 shares left0.3x usual sizeFollows a Form 144Filing

  4. 4 Form 144 notice BTAINotice
    Oct 3, 2024 +17 days

    Filed to sell 7,175 shares ($4k)

    Yocca Frank, Officer

    10b5-1 plan7.3x usual sizeFiling

  5. 5 Form 4 sale BTAIUnusual
    Oct 3, 2024 same day

    Sold 7,175 shares at $0.55 ($4k)

    Yocca Frank, Chief Scientific Officer

    10b5-1 planSold 20.2% of holdings ($19k position)28,278 shares left7.3x usual sizeFollows a Form 144Filing

  6. 6 Form 144 notice BTAINotice
    Dec 16, 2024 +74 days

    Filed to sell 430 shares ($152)

    Yocca Frank, Officer

    10b5-1 planFirst sale on recordFiling

  7. 7 Form 4 sale BTAIRoutine
    Dec 16, 2024 same day

    Sold 430 shares at $0.35 ($152)

    Yocca Frank, Chief Scientific Officer

    10b5-1 planSold 1.5% of holdings ($10k position)28,931 shares leftFirst sale on recordFollows a Form 144Filing

  8. 8 Form 4 sale BTAIUnusual
    May 20, 2026 +520 days

    Sold 6,845 shares at $1.09 ($7k)

    Yocca Frank, Chief Scientific Officer

    10b5-1 planSold 20.7% of holdings ($36k position)26,175 shares left17.1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (16)

Form 144 notices and Form 4 sales by Yocca Frank
Source
May 20, 2026May 22, 2026BTAIChief Scientific OfficerForm 4 sale6,845$7k20.7%UnusualSEC
Dec 16, 2024Dec 17, 2024BTAIChief Scientific OfficerForm 4 sale430$1521.5%RoutineSEC
Dec 16, 2024Dec 16, 2024BTAIOfficerForm 144 notice430$152NoticeSEC
Oct 3, 2024Oct 3, 2024BTAIChief Scientific OfficerForm 4 sale7,175$4k20.2%UnusualSEC
Oct 3, 2024Oct 3, 2024BTAIOfficerForm 144 notice7,175$4kNoticeSEC
Sep 16, 2024Sep 17, 2024BTAIChief Scientific OfficerForm 4 sale355$2452.4%RoutineSEC
Sep 16, 2024Sep 16, 2024BTAIOfficerForm 144 notice355$245NoticeSEC
Jun 17, 2024Jun 18, 2024BTAIChief Scientific OfficerForm 4 sale372$4762.7%RoutineSEC
Jun 17, 2024Jun 17, 2024BTAIOfficerForm 144 notice372$476NoticeSEC
Apr 4, 2024Apr 8, 2024BTAIChief Scientific OfficerForm 4 sale1,067$3k7.7%RoutineSEC
Apr 4, 2024Apr 4, 2024BTAIOfficerForm 144 notice1,067$3kNoticeSEC
Mar 15, 2023Mar 16, 2023BTAIChief Scientific OfficerForm 4 sale985$19k9.4%Plan not statedSEC
Jan 20, 2023Jan 24, 2023BTAIChief Scientific OfficerForm 4 sale50,000$1.5M85.6%UnusualSEC
Mar 15, 2021Mar 17, 2021BTAIChief Scientific OfficerForm 4 sale15,000$728k20.4%Plan not statedSEC
Feb 16, 2021Feb 18, 2021BTAIChief Scientific OfficerForm 4 sale15,000$865k17.0%Plan not statedSEC
Jan 25, 2021Jan 27, 2021BTAIChief Scientific OfficerForm 4 sale15,000$726k14.5%Plan not statedSEC